MX2007000263A - Tratamiento de cancer. - Google Patents

Tratamiento de cancer.

Info

Publication number
MX2007000263A
MX2007000263A MX2007000263A MX2007000263A MX2007000263A MX 2007000263 A MX2007000263 A MX 2007000263A MX 2007000263 A MX2007000263 A MX 2007000263A MX 2007000263 A MX2007000263 A MX 2007000263A MX 2007000263 A MX2007000263 A MX 2007000263A
Authority
MX
Mexico
Prior art keywords
cancer
treatment
leukaemia
preparations
relates
Prior art date
Application number
MX2007000263A
Other languages
English (en)
Inventor
James Peter Burnie
Ruth Christine Matthews
Tracey Carter
Original Assignee
Neutec Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0414885A external-priority patent/GB0414885D0/en
Priority claimed from GB0420845A external-priority patent/GB0420845D0/en
Priority claimed from GB0503566A external-priority patent/GB0503566D0/en
Application filed by Neutec Pharma Ltd filed Critical Neutec Pharma Ltd
Priority claimed from PCT/GB2005/002545 external-priority patent/WO2006003384A1/en
Publication of MX2007000263A publication Critical patent/MX2007000263A/es

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invencion se refiere a medicamentos y preparaciones novedosas que comprenden agentes anti-cancer efectivos junto con un anticuerpo anti-Hsp90 los cuales juntos proveen una eficacia incrementada en el tratamiento de cancer, y leucemia.
MX2007000263A 2004-07-02 2005-06-30 Tratamiento de cancer. MX2007000263A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0414885A GB0414885D0 (en) 2004-07-02 2004-07-02 Cancer therapy
GB0420845A GB0420845D0 (en) 2004-09-20 2004-09-20 Treatment of cancer
US61442304P 2004-09-30 2004-09-30
GB0503566A GB0503566D0 (en) 2005-02-21 2005-02-21 Treatment for cancer
US65445805P 2005-02-22 2005-02-22
PCT/GB2005/002545 WO2006003384A1 (en) 2004-07-02 2005-06-30 Treatment of cancer

Publications (1)

Publication Number Publication Date
MX2007000263A true MX2007000263A (es) 2007-07-20

Family

ID=39124615

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007000263A MX2007000263A (es) 2004-07-02 2005-06-30 Tratamiento de cancer.

Country Status (8)

Country Link
JP (1) JP2008504355A (es)
BR (1) BRPI0512889A (es)
EC (1) ECSP077219A (es)
IL (1) IL180460A (es)
MA (1) MA28701B1 (es)
MX (1) MX2007000263A (es)
NZ (1) NZ552508A (es)
SG (1) SG153877A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008305D0 (en) * 2000-04-06 2000-05-24 Neutec Pharma Plc Treatment of fungal infections

Also Published As

Publication number Publication date
BRPI0512889A (pt) 2008-04-15
ECSP077219A (es) 2007-03-29
SG153877A1 (en) 2009-07-29
IL180460A0 (en) 2007-06-03
JP2008504355A (ja) 2008-02-14
MA28701B1 (fr) 2007-06-01
IL180460A (en) 2010-12-30
NZ552508A (en) 2009-10-30

Similar Documents

Publication Publication Date Title
MX2007003907A (es) Agentes terapeuticos con toxicidad reducida.
UA105210C2 (ru) Противораковая вакцина и ее применение
HK1119071A1 (en) Combinations of therapeutic agents
FR2869231B1 (fr) Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine
CA115590S (en) Back therapy device
EA200602047A1 (ru) Сульфонилэтилфосфородиамидаты, предназначенные для применения при лечении рака
IL184617A0 (en) Dr5 antibodies and uses thereof
TW200642682A (en) A combination of medical drugs to augment the anti-cancer effect of chemotherapy
CA119221S (en) Blister package
NO20070580L (no) Behandling av cancer.
EP1851244A4 (en) ANTI-CD137 ANTIBODY AS A MEANS FOR THE TREATMENT OF CANCER, AND GLYCOSYLATION VARIANTS THEREOF
HK1080447B (zh) 視黃醇衍生物、它們在治療癌症和增强其它細胞毒性劑功效中的應用
WO2008010991A3 (en) Methods and compositions for the treatment of cancer
CY1110329T1 (el) Πεγκυλιωμενη λιποσωμιακη δοξορουβικινη σε συνδυασμο με εκτεϊνασκιδινη 743
IL163902A0 (en) Antibodies against cancer antigen tmeff2 and uses thereof
LU92203I9 (es)
UA99601C2 (ru) Применение антитела к cd151 для лечения первичных опухолей
EA200970885A1 (ru) Комбинирование лечения рака с применением il-18 человека и антитела против cd20
EP1503748A4 (en) DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY
EA200970353A1 (ru) Комбинированное лекарственное средство
PL1713438T3 (pl) Mydło lecznicze
SI1869185T1 (sl) Konjugat ki obsega protein P za zdravljenje raka
CA105215S (en) Packaging with cosmetic composition
GB0111628D0 (en) Binding member
WO2007007152A3 (en) Anti-madcam antibodies to treat metastatic cancers and chloroma

Legal Events

Date Code Title Description
FA Abandonment or withdrawal